223 related articles for article (PubMed ID: 15917502)
1. Attitudes and practices regarding the use of methadone in US state and federal prisons.
Rich JD; Boutwell AE; Shield DC; Key RG; McKenzie M; Clarke JG; Friedmann PD
J Urban Health; 2005 Sep; 82(3):411-9. PubMed ID: 15917502
[TBL] [Abstract][Full Text] [Related]
2. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey.
Nunn A; Zaller N; Dickman S; Trimbur C; Nijhawan A; Rich JD
Drug Alcohol Depend; 2009 Nov; 105(1-2):83-8. PubMed ID: 19625142
[TBL] [Abstract][Full Text] [Related]
3. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
[TBL] [Abstract][Full Text] [Related]
4. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.
Rich JD; McKenzie M; Larney S; Wong JB; Tran L; Clarke J; Noska A; Reddy M; Zaller N
Lancet; 2015 Jul; 386(9991):350-9. PubMed ID: 26028120
[TBL] [Abstract][Full Text] [Related]
5. The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) Prisons Project Study: protocol for a randomised controlled trial comparing methadone and buprenorphine for opiate detoxification.
Sheard L; Wright NM; Adams CE; Bound N; Rushforth B; Hart R; Tompkins CN
Trials; 2009 Jul; 10():53. PubMed ID: 19602218
[TBL] [Abstract][Full Text] [Related]
6. Community-Based Methadone Maintenance in a Large Detention Center is Associated with Decreases in Inmate Recidivism.
Westerberg VS; McCrady BS; Owens M; Guerin P
J Subst Abuse Treat; 2016 Nov; 70():1-6. PubMed ID: 27692182
[TBL] [Abstract][Full Text] [Related]
7. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia.
Wickersham JA; Zahari MM; Azar MM; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2013 Sep; 132(1-2):378-82. PubMed ID: 23414931
[TBL] [Abstract][Full Text] [Related]
8. Methadone maintenance in prison: evaluation of a pilot program in Puerto Rico.
Heimer R; Catania H; Newman RG; Zambrano J; Brunet A; Ortiz AM
Drug Alcohol Depend; 2006 Jun; 83(2):122-9. PubMed ID: 16332415
[TBL] [Abstract][Full Text] [Related]
9. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.
Brinkley-Rubinstein L; McKenzie M; Macmadu A; Larney S; Zaller N; Dauria E; Rich J
Drug Alcohol Depend; 2018 Mar; 184():57-63. PubMed ID: 29402680
[TBL] [Abstract][Full Text] [Related]
10. Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program.
Bachireddy C; Shrestha R; Bromberg DJ; Azbel L; Kurmanalieva A; Wegman M; Shumskaya N; Rozanova J; Meyer JP; Altice FL
Int J Drug Policy; 2022 Mar; 101():103558. PubMed ID: 34915426
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of opioid maintenance programs for treating drug dependence in prisons.
Roselló-Jordá S; Espinós-Navarro C; Molés-Julio MP
Rev Esp Sanid Penit; 2023; 25(3):112-121. PubMed ID: 38289166
[TBL] [Abstract][Full Text] [Related]
12. Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the community in Malaysia.
Ahmad A; Bromberg DJ; Shrestha R; Salleh NM; Bazazi AR; Kamarulzaman A; Shenoi S; Altice FL
Int J Drug Policy; 2024 Apr; 126():104369. PubMed ID: 38484531
[TBL] [Abstract][Full Text] [Related]
13. Optimising opioid substitution therapy in the prison environment.
Alam F; Wright N; Roberts P; Dhadley S; Townley J; Webster R
Int J Prison Health; 2019 Dec; 15(4):293-307. PubMed ID: 31532339
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal.
Moore KE; Oberleitner L; Smith KMZ; Maurer K; McKee SA
J Addict Med; 2018; 12(2):156-162. PubMed ID: 29341974
[TBL] [Abstract][Full Text] [Related]
15. Best Practices for Pregnant Incarcerated Women With Opioid Use Disorder.
Peeler M; Fiscella K; Terplan M; Sufrin C
J Correct Health Care; 2019 Jan; 25(1):4-14. PubMed ID: 30616487
[TBL] [Abstract][Full Text] [Related]
16. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice.
Culbert GJ; Waluyo A; Iriyanti M; Muchransyah AP; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2015 Apr; 149():71-9. PubMed ID: 25659895
[TBL] [Abstract][Full Text] [Related]
17. Opiate replacement therapy at time of release from incarceration: Project MOD, a pilot program.
McKenzie M; Macalino G; McClung C; Shield DC; Rich JD
J Opioid Manag; 2005; 1(3):147-51. PubMed ID: 17315418
[TBL] [Abstract][Full Text] [Related]
18. Linkage with methadone treatment upon release from incarceration: a promising opportunity.
Rich JD; McKenzie M; Shield DC; Wolf FA; Key RG; Poshkus M; Clarke J
J Addict Dis; 2005; 24(3):49-59. PubMed ID: 16186082
[TBL] [Abstract][Full Text] [Related]
19. Initial Management of Incarcerated Pregnant Women With Opioid Use Disorder.
O'Connor A; Bowling N
J Correct Health Care; 2020 Jan; 26(1):17-26. PubMed ID: 31960750
[TBL] [Abstract][Full Text] [Related]
20. Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran.
Moradi G; Farnia M; Shokoohi M; Shahbazi M; Moazen B; Rahmani K
Int J Health Policy Manag; 2015 Mar; 4(9):583-9. PubMed ID: 26340487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
